Sodium thiosulfate - Dr Franz Koehler Chemie
Latest Information Update: 24 Nov 2021
Price :
$50 *
At a glance
- Originator PromediPharm
- Developer Dr Franz Kohler Chemie GmbH
- Class Antidotes; Antituberculars; Chemoprotectants; Thiosulfates; Vasodilators
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Calciphylaxis
Most Recent Events
- 30 May 2018 Dr Franz Kohler Chemie GmbH terminates phase II/III trial in Calciphylaxis in Austria, Germany (IV, infusion) (EudraCT2014-002128-28)
- 21 Dec 2016 Sodium thiosulfate is still in phase II/III trials for Calciphylaxis in Switzerland, Austria and Germany (IV, infusion)
- 01 Oct 2014 Phase-II/III clinical trials in Calciphylaxis in Austria (IV, infusion) (ISRCTN73380053)